Societe Generale Effekten (S29807) Quote

The last two flavors of our terrific ice cream appear to be discontinued...no longer on our website or TT for sale.

Too expensive to ship, or produce in small quantities?

Very disappointed on this end...

IMO, our ice-cream is much better than our cookies.

The wait is over. Did you sell?

What is posted is all I know. I guess we could ask the company or wait for them to post about it.

Good question

The article I read with the numbers was from the Motleyfool . I also explained WHY the numbers were awful . All parties came to an agreement and shipping and sales have resumed . Great lotto play GLTA

Interesting article from Australia
https://www.abc.net.au/news/2024-01-25/adhd-drug-shortage-vyvanse-australia-doctors/103369526

BMXI financials show a profit

Unaudited financials posted on OTCMarkets are not reliable. They can post whatever numbers they want.

this wait is terrible-- wish they would pull off the bandaid-- good or bad- we will know!

BARCHART is pimping 3 junky semiconductor stocks
With the current speculative aka gambling sentiment I won’t dismiss them
https://www.barchart.com/story/news/27373822/3-strong-buy-semiconductor-picks-for-penny-stock-speculators

Recent and undeniable facts about the KEGS scam

1:1000 R/S scheduled for this quarter per disclosure.
20 billion A/S
10.8 billion O/S
$16 million in toxic debt
Never made a profit since inception
.0001 and lower for the past 12 months
12 month

Agree. The actual marketed drug will be named something other than Anavex, and it was just used in a PowerPoint deck.

This is not new or an issue.

This has been this way for years, they take shares rather than $ salary. I would rather that then selling more shares on the open market to get more cash to pay salaries.

This is a non-issue. Try again.

Give it a break! You've commented about 10 times re the alleged taking out trash by Mr. Pineda to the NS dump bin.

still balancing


https://investorshub.advfn.com/uimage/uploads/2024/7/13/dczrjes_12_vpoc.png

Not even close....

Much bigger, much better things going on that will happen sooner than later.

Part A of the phase 2 Anavex 3-71 schizophrenia trial has been completed. I believe that Part B of the phase 2 Anavex 3-71 schizophrenia trial will be completed before the end of summer 2024.

https://classic.clinicaltrials.gov/ct2/show/NCT06245213

Good luck and GOD bles

Medpace, Icon PLC - >>> Ranking the top ten clinical research organisations in the world


GlobalData

by Allie Nawrat

Jun 18, 2024


https://finance.yahoo.com/news/ranking-top-ten-clinical-research-101307245.html

dstock - Exactly, plan A to control NWBO's IP underhandedly has failed to materialize. Which in hindsight they should have realized, that control, without the vision driving the innovation in its various iterations was a bad idea. But the clumsy foresight and lack of vision, likely didn't stop them

#GME 🔥 breakout this week? expecting $30 soon? $GME
https://youtu.be/G0Gr2VdH3lY

Medpace, Icon PLC - >>> Ranking the top ten clinical research organisations in the world


GlobalData

by Allie Nawrat

Jun 18, 2024


https://finance.yahoo.com/news/ranking-top-ten-clinical-research-101307245.html

Yes,I know this..sarcasm.lol..just a way to put a "friend " on the payroll..

https://scontent-lax3-2.xx.fbcdn.net/v/t39.30808-6/449832262_813323974266634_1144415148488233803_n.jpg?_nc_cat=103&ccb=1-7&_nc_sid=833d8c&_nc_ohc=c6W_6PmC-hkQ7kNvgEWGRWf&_nc_ht=scontent-lax3-2.xx&oh=00_AYAhUxTRvGVZfcX-sxk0w7Yyy62Qr1k8pA4Tf7x-YMU9ew&oe=66987E57

https://scontent-lax3-2.

Medpace, Icon PLC - >>> Ranking the top ten clinical research organisations in the world


GlobalData

by Allie Nawrat

Jun 18, 2024


https://finance.yahoo.com/news/ranking-top-ten-clinical-research-101307245.html

Jelly and Jam, sorry for the delay in answering your question, you are, for sure, getting a buzz cut! Congratulations!

"Will that payment be for the amount I have sitting
in my account now? or will they 12/1 split that escrow
and then pay $8.00 on that.

north, if Amarin had competent attorneys who conducted the "thorough" analysis and understood the technology Hikma wouldn't have been able to poke holes in the application.